Pancreatic Enzyme Replacement Therapy: Shortages
Commons · Question 10329 · Tabled 21 Oct 2024 · Department of Health and Social Care · Official record
Answered 25 Oct 2024
Question
Asked by Paul Davies
To ask the Secretary of State for Health and Social Care, whether he plans to introduce a national plan to tackle shortages of pancreatic enzyme replacement therapy.
Answer
Answered by Karin Smyth, 25 Oct 2024
The Department has been working with suppliers to address current supply issues with Creon, which is a brand of pancreatic enzyme replacement therapy (PERT) used by patients with conditions such as cystic fibrosis and certain cancers including pancreatic ...